Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Business Models and Strategy

 

Eight predictions for for-profit health care in 2023

2022 was a tumultuous year for for-profit health care. The year began with a sense of things returning to a new normal, after the major disruption of the Covid pandemic throughout 2020 and 2021. But then, not even two months in, Russia invaded Ukraine, and this quickly led to an energy and economic crisis throughout Europe. For the first time in decades inflation reached double-digit figures across almost every OECD country and the era of near-zero interest rates came to an abrupt end. The second half of the year saw major worries about a looming recession and a potential debt crisis, rapidly falling investment and M&A deal volumes slowing to almost a standstill.

Portuguese competition authority goes after labs

Portugal’s competition authority (AdC) has opened an investigation into collusion it suspects took place between several of the country’s major labs groups during the years 2016 and 2022. The accused groups include Affidea, Synlab and Unilabs subsidiaries.

Orpea rescue plan meets opposition

Under-fire French elderly care operator Orpea could have a shareholder revolt on its hands. Unhappy with plans for massive share price dilution as the group looks to meet its debts, a group of disillusioned shareholders has suggested an alternative and is looking for support. HBI speaks to two French health care experts to learn more.

TVM Capital Healthcare raising outpatient SE Asia fund

Dubai and Singapore based private equity firm TVM Capital Healthcare is raising a new emerging market fund which will invest in non-hospital health care assets in the South East Asia region. The fund has a target of $200m and is expected to make its first investment in the first half of 2023.

Health care companies must learn to deal with cyber attacks

Cyber attacks on health care are on the rise, and operators focused on preventing attacks need to think more about developing resilience to ensure critical care is protected. HBI speaks to Trevor Dearing, director of critical infrastructure solutions at cybersecurity firm Illumio, to find out more.

BMA targets ‘unregulated’ at-home diagnostic tests

In October the British Medical Association (BMA) reported it had found cases of private labs groups offering direct-to-consumer at-home diagnostic tests with ‘misleading’ claims about their accuracy, claiming some of these tests are unregulated. The NHS says such tests risk overburdening GPs with patients who have received misleading information. HBI speaks to Kevin Dryhurst, CEO of private labs operator DAM Health, who argues privately provided direct-to-consumer tests have a role to play in providing some of the preventive care which the NHS is failing to deliver.

FMC CEO leaves after just two months in post

Global renal disease specialist Fresenius Medical Care has parted ways with its new CEO just months after announcing her appointment, and scarcely two months after she took up her post. HBI looks at the surprisingly quick turnaround and tries to work out what happened.

Chris Toth, CEO, Varian, a Siemens Healthineers Company

In April last year, medical device giant Siemens Healthineers acquired Varian Medical Systems in one of the largest all cash MedTech transactions in history. HBI catches up with Varian CEO Chris Toth to find out more about the deal, and Varian’s plans for the future. 

Viamed chooses Synlab to run in-house labs

Spanish hospital group Viamed has chosen Synlab to run its in-house diagnostic labs in many of its hospitals, meaning less outsourced business for Eurofins.

Spanish hospitals bringing labs in-house

Major Spanish hospital groups are bringing their diagnostic labs testing in-house, in a trend which stands in direct contrast to what is happening in other countries.

Find Us